University of Pittsburgh Law Review, ISSN 0041-9915, 09/2016, Volume 78, Issue 1, pp. 117 - 134
Expert opinions are a fundamental strategic component in the field of products liability litigation. The success of a party’s claim or defense often depends...
LAW | Evidence, Expert | Evidence (Law) | Laws, regulations and rules | Products liability
LAW | Evidence, Expert | Evidence (Law) | Laws, regulations and rules | Products liability
Journal Article
PLoS medicine, ISSN 1549-1277, 2015, Volume 12, Issue 3, pp. e1001809 - e1001809
Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and...
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
Journal Article
Journal of Biological Regulators and Homeostatic Agents, ISSN 0393-974X, 2012, Volume 26, Issue 1, p. S113
Patients with pollen allergy may frequently present an additional food-related allergy (Oral Allergic Syndrome, OAS), as consequence of cross-reactivity...
Proliferations | Birch allergy | Bet v 1 | Oral allergic syndrome | Administration, Oral | Humans | Adult | Antigens, Plant - immunology | Female | Male | Food Hypersensitivity - etiology | Malus - immunology
Proliferations | Birch allergy | Bet v 1 | Oral allergic syndrome | Administration, Oral | Humans | Adult | Antigens, Plant - immunology | Female | Male | Food Hypersensitivity - etiology | Malus - immunology
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 2018, Volume 21, Issue 3, pp. 1 - n/a
There is paucity of data related to potential gender differences in the use of interventions to prevent and treat cardiovascular disease (CVD) among...
cardiovascular disease interventions | gender | HIV | myocardial infarction | cohort studies | Cardiovascular disease | stroke | women | Myocardial infarction | Women | Stroke | Hiv | Cohort studies | Cardiovascular disease interventions | Gender | Cardiovascular Diseases - etiology | HIV Seropositivity - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Adult | Female | Male | Sex Characteristics | Cohort Studies | INFECTIOUS DISEASES | RISK-FACTORS | IMMUNOLOGY | ACUTE CORONARY SYNDROME | HEART-DISEASE | GENERAL-POPULATION | CASE-FATALITY | CLINICAL PRESENTATION | ACUTE MYOCARDIAL-INFARCTION | INFECTED PATIENTS | IN-HOSPITAL MORTALITY | SEX-DIFFERENCES | Prevention | HIV patients | Care and treatment | Cardiovascular diseases | Health aspects | Gender differences | Acquired immune deficiency syndrome--AIDS | Health risk assessment | Human immunodeficiency virus--HIV | Mortality
cardiovascular disease interventions | gender | HIV | myocardial infarction | cohort studies | Cardiovascular disease | stroke | women | Myocardial infarction | Women | Stroke | Hiv | Cohort studies | Cardiovascular disease interventions | Gender | Cardiovascular Diseases - etiology | HIV Seropositivity - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Adult | Female | Male | Sex Characteristics | Cohort Studies | INFECTIOUS DISEASES | RISK-FACTORS | IMMUNOLOGY | ACUTE CORONARY SYNDROME | HEART-DISEASE | GENERAL-POPULATION | CASE-FATALITY | CLINICAL PRESENTATION | ACUTE MYOCARDIAL-INFARCTION | INFECTED PATIENTS | IN-HOSPITAL MORTALITY | SEX-DIFFERENCES | Prevention | HIV patients | Care and treatment | Cardiovascular diseases | Health aspects | Gender differences | Acquired immune deficiency syndrome--AIDS | Health risk assessment | Human immunodeficiency virus--HIV | Mortality
Journal Article
BMC infectious diseases, ISSN 1471-2334, 2013, Volume 13, Issue 1, pp. 471 - 471
Non-AIDS defining cancers (NADC) are an important cause of morbidity and mortality in HIV-positive individuals. Using data from a large international cohort of...
Prognosis | Non-AIDS defining cancers | Trends | HIV | Incidence | UNITED-STATES | INFECTIOUS DISEASES | BONE-MARROW-TRANSPLANTATION | RISK | HODGKINS-DISEASE | ACTIVE ANTIRETROVIRAL THERAPY | SWISS HIV COHORT | ANAL CANCER | MALIGNANCIES | INFECTED PATIENTS | IMMUNODEFICIENCY | Prospective Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasms - mortality | Male | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Mortality | Patient outcomes | AIDS (Disease) | United Kingdom | Research | Statistics | Cancer | Lung cancer | Analysis | Oncology, Experimental | Lymphomas | HIV (Viruses) | Health aspects | Risk factors | Netherlands | France | Australia | Spain | Acquired immune deficiency syndrome--AIDS | Pharmaceutical industry | Drug therapy | Human immunodeficiency virus--HIV | Life Sciences | Microbiology and Parasitology
Prognosis | Non-AIDS defining cancers | Trends | HIV | Incidence | UNITED-STATES | INFECTIOUS DISEASES | BONE-MARROW-TRANSPLANTATION | RISK | HODGKINS-DISEASE | ACTIVE ANTIRETROVIRAL THERAPY | SWISS HIV COHORT | ANAL CANCER | MALIGNANCIES | INFECTED PATIENTS | IMMUNODEFICIENCY | Prospective Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasms - mortality | Male | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Mortality | Patient outcomes | AIDS (Disease) | United Kingdom | Research | Statistics | Cancer | Lung cancer | Analysis | Oncology, Experimental | Lymphomas | HIV (Viruses) | Health aspects | Risk factors | Netherlands | France | Australia | Spain | Acquired immune deficiency syndrome--AIDS | Pharmaceutical industry | Drug therapy | Human immunodeficiency virus--HIV | Life Sciences | Microbiology and Parasitology
Journal Article